NCT00403078View on ClinicalTrials.gov

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

CompletedOBSERVATIONAL

Enrollment

21,008

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2014

Study Completion Date

November 30, 2014

Conditions

Carotid Artery Disease

Trial Locations (5)

17110

Harrisburg Hospital, Harrisburg

19713

Christiana Care Health Services, Newark

37660

The Heart Center, PC, Kingsport

50266

Iowa Clinic, Heart & Vascular Care, West Des Moines

68506

Bryan LGH Heart Institute, Lincoln

Sponsors

Lead Sponsor

Cordis Corporation

All Listed Sponsors

lead

Cordis Corporation

INDUSTRY

NCT00403078 - SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy | Biotech Hunter | Biotech Hunter